Koen Oosterhuis

589 total citations
19 papers, 482 citations indexed

About

Koen Oosterhuis is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Koen Oosterhuis has authored 19 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Koen Oosterhuis's work include Immunotherapy and Immune Responses (14 papers), Cervical Cancer and HPV Research (5 papers) and vaccines and immunoinformatics approaches (4 papers). Koen Oosterhuis is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Cervical Cancer and HPV Research (5 papers) and vaccines and immunoinformatics approaches (4 papers). Koen Oosterhuis collaborates with scholars based in Netherlands, Germany and United States. Koen Oosterhuis's co-authors include John B.A.G. Haanen, Ton N. Schumacher, Joost H. van den Berg, Grietje Molema, Sigrídur A. Ásgeirsdóttir, Jan P. Schouten, Johanna Westra, Robbert J. Kok, Marianne G. Rots and Pieter C. Limburg and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and International Journal of Cancer.

In The Last Decade

Koen Oosterhuis

18 papers receiving 463 citations

Peers

Koen Oosterhuis
Andrea L. George United States
Koen Oosterhuis
Citations per year, relative to Koen Oosterhuis Koen Oosterhuis (= 1×) peers Andrea L. George

Countries citing papers authored by Koen Oosterhuis

Since Specialization
Citations

This map shows the geographic impact of Koen Oosterhuis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koen Oosterhuis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koen Oosterhuis more than expected).

Fields of papers citing papers by Koen Oosterhuis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koen Oosterhuis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koen Oosterhuis. The network helps show where Koen Oosterhuis may publish in the future.

Co-authorship network of co-authors of Koen Oosterhuis

This figure shows the co-authorship network connecting the top 25 collaborators of Koen Oosterhuis. A scholar is included among the top collaborators of Koen Oosterhuis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koen Oosterhuis. Koen Oosterhuis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Oosterhuis, Koen, et al.. (2025). Effect of bluetongue serotype 3 vaccines on probability of viremia and NSAID usage in Dutch dairy cattle herds. Frontiers in Veterinary Science. 12. 1619614–1619614.
2.
Oosterhuis, Koen, Marcel Camps, Tsolère Arakelian, et al.. (2024). Neoantigen-specific T cell help outperforms non-specific help in multi-antigen DNA vaccination against cancer. SHILAP Revista de lepidopterología. 32(3). 200835–200835. 4 indexed citations
3.
Arakelian, Tsolère, Koen Oosterhuis, Elena Tondini, et al.. (2022). Pyroptosis-inducing active caspase-1 as a genetic adjuvant in anti-cancer DNA vaccination. Vaccine. 40(13). 2087–2098. 20 indexed citations
4.
Tondini, Elena, Tsolère Arakelian, Koen Oosterhuis, et al.. (2019). A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control. OncoImmunology. 8(11). 1652539–1652539. 52 indexed citations
5.
Vujadinovic, Marija, Selina Khan, Koen Oosterhuis, et al.. (2018). Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses. Vaccine. 36(30). 4462–4470. 18 indexed citations
6.
Khan, Selina, Koen Oosterhuis, Kerstin Wunderlich, et al.. (2017). Development of a replication‐deficient adenoviral vector‐based vaccine candidate for the interception of HPV16‐ and HPV18‐induced infections and disease. International Journal of Cancer. 141(2). 393–404. 24 indexed citations
7.
Boerma, Annemarie, Michał Walczak, Koen Oosterhuis, et al.. (2015). Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccines. Gene Therapy. 22(7). 560–567. 16 indexed citations
8.
Berg, Joost H. van den, Koen Oosterhuis, Ton N. Schumacher, John B.A.G. Haanen, & Adriaan D. Bins. (2014). Intradermal Vaccination by DNA Tattooing. Methods in molecular biology. 1143. 131–140. 14 indexed citations
9.
Gomez-Eerland, Raquel, Joost H. van den Berg, Koen Oosterhuis, et al.. (2013). Transposon leads to contamination of clinical pDNA vaccine. Vaccine. 31(32). 3274–3280. 10 indexed citations
10.
Henken, Florianne E, Koen Oosterhuis, Peter Öhlschläger, et al.. (2012). Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7. Vaccine. 30(28). 4259–4266. 10 indexed citations
11.
Oosterhuis, Koen, Esil Aleyd, Kim Vrijland, Ton N. Schumacher, & John B.A.G. Haanen. (2012). Rational Design of DNA Vaccines for the Induction of Human Papillomavirus Type 16 E6- and E7-Specific Cytotoxic T-Cell Responses. Human Gene Therapy. 23(12). 1301–1312. 35 indexed citations
12.
Oosterhuis, Koen. (2012). Preclinical development of DNA vaccine candidates for the treatment of HPV16 induced malignancies. Data Archiving and Networked Services (DANS). 1 indexed citations
13.
Oosterhuis, Koen, Peter Öhlschläger, Joost H. van den Berg, et al.. (2011). Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7. International Journal of Cancer. 129(2). 397–406. 29 indexed citations
14.
Berg, Joost H. van den, Koen Oosterhuis, Jos H. Beijnen, Bastiaan Nuijen, & John B.A.G. Haanen. (2010). DNA Vaccination in Oncology: Current Status, Opportunities and Perspectives. Current Clinical Pharmacology. 5(3). 218–225. 2 indexed citations
15.
Oosterhuis, Koen, Joost H. van den Berg, Ton N. Schumacher, & John B.A.G. Haanen. (2010). DNA Vaccines and Intradermal Vaccination by DNA Tattooing. Current topics in microbiology and immunology. 351. 221–250. 24 indexed citations
16.
Berg, Joost H. van den, Koen Oosterhuis, Wim E. Hennink, et al.. (2009). Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity. Journal of Controlled Release. 141(2). 234–240. 57 indexed citations
17.
Berg, Joost H. van den, et al.. (2009). DNA tattoo vaccination: Effect on plasmid purity and transfection efficiency of different topoisoforms. Journal of Controlled Release. 139(2). 153–159. 16 indexed citations
18.
Ogawara, Ken‐ichi, Koen Oosterhuis, Bart‐Jan Kroesen, et al.. (2006). Functional inhibition of NF-κB signal transduction in αvβ3 integrin expressing endothelial cells by using RGD-PEG-modified adenovirus with a mutant IκB gene. Arthritis Research & Therapy. 8(1). R32–R32. 23 indexed citations
19.
Westra, Johanna, Sigrídur A. Ásgeirsdóttir, Robbert J. Kok, et al.. (2005). Differential effects of NF-κB and p38 MAPK inhibitors and combinations thereof on TNF-α- and IL-1β-induced proinflammatory status of endothelial cells in vitro. American Journal of Physiology-Cell Physiology. 289(5). C1229–C1239. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026